The objective of this contract program is to maintain and operate a Synthetic Peptide Facility for the synthesis of large quantities of previously prepared peptides (up to 20 grams via single-batch preparation of multiple small-batch preparation (5-10 batches)) as well as relatively smaller quantities (5-100 mg) of novel peptides.
| Wallen, K; Eisler, J A; Tannenbaum, P L et al. (1991) Antide (Nal-Lys GnRH antagonist) suppression of pituitary-testicular function and sexual behavior in group-living rhesus monkeys. Physiol Behav 50:429-35 |
| Hoeger, C; Porter, J; Boublik, J et al. (1989) Preparative-scale synthesis and reversed-phase purification of a gonadotropin-releasing hormone antagonist. J Chromatogr 484:307-18 |
